Flywire
PassportCard

iPMI Market Interviews

Interviews

iPMI Global Speaks With Madhur Srivastava, CEO, DocHQ

In this exclusive iPMI Global interview, Christopher Knight, CEO, iPMI Global, met with Madhur Srivastava, CEO at DocHQ. They discussed in detail the DocHQ journey, to revolutionise the approach to employee benefits, insurance, and healthcare through the lens of technology.

28-11-2023 iPMI Global

Interviews

iPMI Global Speaks with Natalya Butakova, CEO, AP Companies Group

In this exclusive iPMI Global interview, Christopher Knight, CEO, iPMI Global, met with Natalya Butakova, CEO, AP Companies Group. They discussed 2023 in detail and looked at the achievements of AP Companies Group over the past year.

16-01-2024 iPMI Global

International Private Medical Insurance

iPMI Insights

Black Friday with iPMI Global: Save on 2 Major Market Research Reports

International Health Insurance 2024: The Future of International Private Medical Insurance (iPMI) The 2024 iPMI report on the international private medical insurance (iPMI) market, authored by Ian Youngman. The report analyses iPMI market trends, including growth drivers like high-net-worth individuals and international students, and the impact of partnerships and technological advancements. It also profiles 177 countries, 85 insurance companies, and 49 brokers/MGAs. The report is available for purchase in full or modular formats, with discounts for advertisers and subscribers. Accompanying news...

29-11-2024 iPMI Global

iPMI Insights

Global Factors Contributing to Rising International Private Medical Insurance Premiums

In this iPMI Global Insights article, iPMI analyst Christopher Knight reads Pacific Prime’s new iPMI report, which explores the global factors that are contributing to the rising cost of international private medical insurance. The report analyses trends in individual and family International Private Medical Insurance (IPMI) premiums across 100 locations, highlighting key global and regional factors influencing these costs.

12-11-2024 iPMI Global

iPMI Insights

Analysing iPMI Premiums for Individual and Family Plans Across 100 Global Locations

Pacific Prime, a global health insurance brokerage and employee benefits specialist, has released its annual Cost of International Health Insurance (COHI) Report 2024, analyzing IPMI premiums for individual and family plans across 100 global locations.

12-11-2024 iPMI Global

Expatriate Healthcare Insurance News

Expat Employees in Middle East Call for Workplace Pension Schemes

A survey of 1,504 expatriate workers in Qatar, Saudi Arabia and the United Arab Emirates has highlighted contrasting views on workplace benefits. While 84% of those surveyed cited the benefits offered by their employer as playing a role in their decision to move to the Gulf, there is widespread dissatisfaction with the region’s End of Service Gratuity (EoSG) system. These one-off severance payments, a common practice in the Gulf Cooperation Council (GCC) region, are deemed insufficient for meeting retirement needs by 60%...

12-11-2024 iPMI Global

Country Guides

Everest Insurance International® Unveils New Health Insurance Partnership to Transform Employee Care in Singapore

Everest Insurance International has enhanced its growing Accident and Health (A&H) offerings with the launch of Innovator, an AI-driven international private medical insurance product that aims to redefine the standards of employee health coverage. The product is first available in Singapore and was developed in collaboration with DocDoc and AXA Life and Health Reinsurance Solutions.

10-11-2024 iPMI Global

Country Guides

Navigating the LATAM iPMI Market with Best Doctors Insurance

In the iPMI Global Regional article, we discover how Best Doctors Insurance can help expatriates, travellers and tourists navigate the healthcare systems in Latin America. We review the key themes and insights from an interview with Sheldon Kenton, CEO of Best Doctors Insurance, published by iPMI Global. The interview focuses on the company's position in the Latin American international private medical insurance (IPMI) market, highlighting its strategies, the challenges, and opportunities.

08-11-2024 iPMI Global

Healthcare Leaders Across India Bring NVIDIA NIM for Hindi Language to LLM Applications

Life sciences and healthcare organizations across India are using generative AI to build applications that can deliver life-saving impacts — within the country and across the globe.

Among such leading organizations are research centers at the Indian Institute of Technology Madras (IIT Madras) and the Indraprastha Institute of Information Technology Delhi (IIIT-Delhi), intelligent life sciences company Innoplexus and AI-led medical diagnostics platform provider 5C Network.

Central to their work are NVIDIA NIM microservices, including the new Nemotron-4-Mini-Hindi 4B microservice for building sovereign AI applications and large language models (LLMs) in the Hindi language.

The Nemotron-4 Hindi model delivers the highest accuracy across benchmarks in 2 billion to 8 billion model-size categories for Hindi.

With the Indian healthcare market projected to grow from about $180 billion last year to $320 billion by 2028, the new AI model has the potential to dramatically improve healthcare accessibility and efficiency.

To gear up for such growing demands — and to help more patients faster — the Indian government is significantly investing in building foundational AI models designed and developed within the country, including for healthcare, through initiatives like the IndiaAI Mission.

Members of the Indian healthcare ecosystem are leading the charge by advancing neuroscience research, combating antibiotic resistance, accelerating drug discovery, automating diagnostic scan analysis and more — all with AI’s help.

IIT Madras Advances Neuroscience Research With AI 

The IIT Madras Brain Centre is advancing neuroscience research by imaging whole human brains at a cellular level across various ages and brain diseases, and using AI to analyze these vast petabyte-sized primary datasets. The work is opening new avenues for understanding brain structure and function, as well as how they change in disease conditions, accelerating research that could lead to life-saving discoveries.

To make information about the brain more accessible to STEM students and researchers, the center is developing an AI chatbot — using the Nemotron-4 Hindi NIM microservice — that can answer neuroscience-related questions in Hindi.

This builds upon the center’s existing NVIDIA AI-powered knowledge-exploration framework, called Neuro Voyager. Developed using visual question-answering models and LLMs, Neuro Voyager lets researchers submit queries related to brain images and provides highly accurate answers using multimodal information retrieval.

IIT Madras developed Neuro Voyager using both real-world data from research publications and synthetic data.

Using NVIDIA NeMo Retriever, a collection of NIM microservices for information retrieval, the team achieved a 30% increase in accuracy through fine-tuning of the embedding model and further refinement of the framework.

For the tool’s answer-generation portion, the researchers tapped the Llama 3.1 70B NVIDIA NIM microservice, running on NVIDIA DGX systems, which accelerated LLM inference 4x compared with the native model.

IIIT-Delhi-Led Consortium Fights Antimicrobial Resistance Using Generative AI, NVIDIA DGX

A research group at IIIT-Delhi is using the Nemotron-4 Hindi model to collect antibiotic prescription patterns in local languages, including Hindi.

Antimicrobial resistance — among the world’s greatest threats to global health — occurs when bacteria, viruses, fungi and parasites change over time, no longer responding to treatment and increasing the risk of disease spread, severe illness and death.

IIIT-Delhi researchers predict that AI-guided antimicrobial stewardship will be a key component of preventing the tens of millions of deaths that could be caused by antimicrobial resistance between 2025 and 2050.

The researchers’ AI-powered data integration and predictive analytics tool, AMRSense, improves accuracy and speeds time to insights on antimicrobial resistance. Powered by NVIDIA NeMo platform-based natural language processing, AMRSense is designed to be used in hospital and community settings.

This collaborative solution between IIIT-Delhi and a consortium of other research institutions placed second out of over 300 entries in the Trinity Challenge, a competition that calls for data-driven solutions to help tackle global health threats.

IIIT-Delhi is also using NVIDIA DGX systems to build foundation models that can further hone its workflows.

5C Network Uses NVIDIA NIM, MONAI for AI-Powered Medical Imaging

Bengaluru- and Coimbatore-based 5C Network’s Bionic suite of medical imaging tools, based on computer vision and LLMs, is helping transform radiology reporting by reading, detecting and analyzing medical scans and generating comprehensive medical notes that provide actionable insights to support clinicians in decision-making.

Used across India’s largest hospital groups and several marquee hospitals, Bionic detects pathologies in scans, such as lung lesions in X-rays or brain masses in MRIs. It then provides detailed measurements of abnormalities, such as the size, volume or density of lesions to assess disease severity and treatment planning. Finally, Bionic compiles the data into clear, actionable reports with suggested next steps, such as further testing or specialist referrals.

Bionic was developed using the open-source MONAI framework, the NVIDIA TensorRT ecosystem of application programming interfaces for high-performance deep learning inference, and the NVIDIA NeMo platform for custom generative AI.

Using the Nemotron-4 Hindi NIM microservice, 5C Network is now enhancing its client app, which allows patients to ask questions about radiology reports and receive quick, accurate responses in simplified Hindi.

Innoplexus Analyzes Protein Interactions With NVIDIA NIM

Innoplexus, a member of the NVIDIA Inception program for cutting-edge startups, has built an AI-powered life sciences platform for drug discovery powered by NVIDIA NIM, including the AlphaFold2 NIM microservice.

Protein-protein interaction (PPI) is critical to pathogenic and physiologic mechanisms that trigger the onset and progression of diseases. This means understanding PPI can help facilitate effective diagnostic and therapeutic strategies.

Innoplexus performs large-scale PPI predictions up to 500x faster than traditional methods. The company’s platform can analyze 200 million protein interactions in just seconds, tapping into NVIDIA H100 Tensor Core GPU acceleration.

Using NVIDIA NIM microservices, Innoplexus generates synthetic patient data to boost its AI models and performs virtual screenings of 5.8 million small molecules in less than eight hours — 10x faster than without NIM.

Plus, the microservices help Innoplexus identify the most effective, safest drugs within a given set of therapeutic agents with 90% accuracy.​

Using the new Nemotron-4 Hindi model, Innoplexus is developing a tool that will let users easily access and understand information about Ayurveda, a system of traditional medicine native to India, based on Hindi content from key repositories.

Another Innoplexus LLM application, built with the new Hindi model, explains details about user prescriptions and medical reports — based on photos of them — in easy-to-understand terms.

NVIDIA NIM microservices are available as part of the NVIDIA AI Enterprise software platform. Developers can get started with them for free at ai.nvidia.com.

In addition, global system integrators including Infosys, Tata Consultancy Services (TCS), Tech Mahindra and Wipro are collaborating with NVIDIA to help life sciences and healthcare companies accelerate their generative AI adoption.

UnitedHealthcare Global
Cigna
Flywire

Welcome To iPMI Global

iPMI Global is the leading business intelligence provider for international private medical, health, travel and expatriate insurance markets worldwide. Due to the nomadic nature of the international private medical insurance (IPMI) market, iPMI Global is an internet based news service for worldwide insurance and medical assistance professionals who need to understand the impacts of insurance and healthcare policy, regulatory, and legislative developments.

Senior level business executives, in over 120 countries, rely on iPMI Global to stay 1 step ahead of the risk and on the inside track of international PMI.

Covering business travellers, high net worth individuals, expatriate and leisure travel markets, iPMI Global is the only international news source covering the most exciting sector of international health insurance: international private medical insurance.

Socials